{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:30:02Z","timestamp":1770273002327,"version":"3.49.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>\n                    Primary hyperparathyroidism (PHPT) is an excessive secretion of PTH caused by a defect in parathyroid cells, insensitive to the suppressive effects of hypercalcemia. The effect of 25-hydroxyvitamin D3 (25-OH-D) and skeletal and extra-skeletal conditions is well known, but the impact of 25-OH-D and 1,25-OH-D in the pathogenesis of primary hyperparathyroidism (PHPT) is still poorly researched. The study group (SG) consists of 85 patients with diagnosed PHPT. The control group (CG) consists of 51 patients without calcium-phosphate imbalance. The SG was divided into two subgroups: SG1 (patients with PHPT qualified for conservative management) and SG2 (patients who are qualified for surgical treatment). Serum PTH, calcium and phosphates concentration were assessed as well as the concentration of 25-OH-D and 1,25-OH-D. The ratio of 1,25-OH-D to 25-OH-D was introduced: vitamin D activation ratio (VD-AR). The median concentration of 25-OH-D3: 30,00 ng\/mL in CG, 32,75 ng\/ml in SG1 and 27,6 ng\/mL in SG2. The highest 1,25-OH-D3 median concentration was found among patients in SG2 (91,1 pg\/mL) lower in SG1 (64,05 pg\/mL) and the lowest in CG (46,20 pg\/mL). VD-AR was highest in SG2 as well, with median 3,32. Results given prove the statistically significant differences between the medians of 1,25-OH-D and VD-AR between pairs of all groups (e.g. SG1\n                    <jats:italic>vs<\/jats:italic>\n                    . SG2; SG1\n                    <jats:italic>vs<\/jats:italic>\n                    . CG etc.). In the logit model for calcium, the structural parameter for the VD-AR was statistically significant-the higher the value of VD-AR the greater the probability of hypercalcemia above 11 mg\/dL (74.1%). In the logit model for indication for parathyroidectomy, the structural parameter for the VD-AR and iPTH was statistically significant at 0.05 significance level, which means that higher value of VD-AR the greater probability of surgery and independently the higher serum concentration of iPTH the greater probability of surgery as well (72.9%) To conclude, 1,25-OH-D serum concentration and VD-AR are significantly higher in PHPT patients than in the healthy population. 1,25-OH-D serum concentration and VD-AR are significantly higher in PHPT patients qualified to surgery than qualified to conservative treatment. Moreover, higher value of VD-AR makes greater probability of hypercalcemia above 11 mg\/dL. We suggest VD-AR cut-off 3.3 as clinically relevant.\n                  <\/jats:p>","DOI":"10.3389\/fendo.2025.1700345","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T05:16:50Z","timestamp":1764825410000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Can vitamin D supplementation be dangerous? 25-Hydroxyvitamin D and 1,25-hydroxyvitamin D concentration in healthy population and primary hyperparathyroidism: a single-center experience and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"\u0141ukasz","family":"Obo\u0142o\u0144czyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Berendt-Obo\u0142o\u0144czyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Sworczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izabela","family":"Karwacka-Bujak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Majerowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Renke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41574-021-00593-z","article-title":"The health effects of vitamin D supplementation: evidence from human studies","volume":"18","author":"Bouillon","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1554714","article-title":"Vitamin D in thyroid disorders","volume":"123","author":"Kmie\u0107","year":"2015","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1024\/0300-9831\/a000798","article-title":"Accidental vitamin D3 overdose in a young man","volume":"94","author":"Nekoukar","year":"2024","journal-title":"Int J Vitam Nutr Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2174\/1871530320666201007152230","article-title":"How much vitamin D is too much? A case report and review of the literature","volume":"21","author":"De Vincentis","year":"2021","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/bmjnph-2021-000382","article-title":"Cost-effectiveness of vitamin D3 supplementation in older adults with vitamin D deficiency in Ireland","volume":"5","author":"Lacey","year":"2022","journal-title":"BMJ Nutr Prev Health"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae290","article-title":"Vitamin D for the prevention of disease: an endocrine society clinical practice guideline","volume":"109","author":"Demay","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8821292","article-title":"FGF23: A review of its role in mineral metabolism and renal and cardiovascular disease","volume":"2021","author":"Kurpas","year":"2021","journal-title":"Dis Markers"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.104","article-title":"Primary hyperparathyroidism","volume":"14","author":"Walker","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1163877","article-title":"Improvement of hypertension control and left-ventricular function after cure of primary hyperparathyroidism","volume":"14","author":"Karwacka","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/JAMA.1934.02750160010003","article-title":"Hyperparathyroidism: common and polymorphic condition as illustrated by seventeen proven cases from one clinic","volume":"102","author":"Albright","year":"2021","journal-title":"J Am Med Assoc"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2478\/v10039-012-0062-2","article-title":"Prevalence of primary hyperparathyroidism among patients with low bone mass","volume":"57","author":"Misiorowski","year":"2012","journal-title":"Adv Med Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.5603\/ep.103003","article-title":"Contemporary localization diagnostics in primary hyperparathyroidism. Review of visualization techniques including ultrasonography, PTH washout, 99mTc-MIBI scintigraphy, and 18F-choline PET","volume":"76","author":"Witowska","year":"2025","journal-title":"Endokrynol Pol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10010123","article-title":"The current role of parathyroid fine-needle biopsy (P-FNAB) with iPTH-washout concentration (iPTH-WC) in primary hyperparathyroidism: A single center experience and literature review","volume":"10","author":"Obo\u0142o\u0144czyk","year":"2022","journal-title":"Biomedicines"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2018.12.003","article-title":"Epidemiology of parathyroid disorders","volume":"32","author":"Rao","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4665","article-title":"Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism","volume":"37","author":"Minisola","year":"2022","journal-title":"J Bone Miner Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4682","article-title":"Management of primary hyperparathyroidism","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"key":"B18","article-title":"Institute of medicine (US) committee to review dietary reference intakes for vitamin D and calcium","volume-title":"Dietary reference intakes for calcium and vitamin D","author":"Ross","year":""},{"key":"B19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3177\/jnsv.66.497","article-title":"Vitamin D in the dietary reference intakes for Japanese (DRIs) 2020","volume":"66","author":"Tanaka","year":"2020","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.111.013268","article-title":"The vitamin D status of Canadians relative to the 2011 Dietary Reference Intakes: an examination in children and adults with and without supplement use","volume":"94","author":"Whiting","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae312","article-title":"A systematic review supporting the endocrine society clinical practice guidelines on vitamin D","volume":"109","author":"Shah","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/nu15030695","article-title":"Guidelines for preventing and treating vitamin D deficiency: A 2023 update in Poland","volume":"15","author":"P\u0142udowski","year":"2023","journal-title":"Nutrients"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12269","article-title":"Prolonged vitamin D intoxication: presentation, pathogenesis and progress","volume":"43","author":"Bell","year":"2013","journal-title":"Intern Med J"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-022-01543-2","article-title":"Two cases of severe vitamin D3 intoxication treated with therapeutic plasma exchange and high cut-off hemodialysis","volume":"36","author":"Heister","year":"2023","journal-title":"J Nephrol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-023-03124-w","article-title":"Long-term supplementation with 3200 to 4000 IU of vitamin D daily and adverse events: a systematic review and meta-analysis of randomized controlled trials","volume":"62","author":"Zittermann","year":"2023","journal-title":"Eur J Nutr"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e240132","DOI":"10.1530\/EDM-24-0132","article-title":"Rare presentation of vitamin D toxicity with hypertriglyceridemia and pancreatitis","volume":"2025","author":"Rehman","year":"2025","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/er.2016-1070","article-title":"Vitamin D-mediated hypercalcemia: mechanisms, diagnosis, and treatment","volume":"37","author":"Tebben","year":"2016","journal-title":"Endocr Rev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00550","article-title":"Vitamin D toxicity-A clinical perspective","volume":"9","author":"Marcinowska-Suchowierska","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.ijem_223_21","article-title":"Prevalence and etiological profile of hypercalcemia in hospitalized adult patients and association with mortality","volume":"26","author":"Sulaiman","year":"2022","journal-title":"Indian J Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e10415","DOI":"10.1002\/jbm4.10415","article-title":"Low 25-hydroxyvitamin D in primary hyperparathyroidism: enhanced conversion into 1,25-hydroxyvitamin D may not be \"True\" Deficiency","volume":"4","author":"Kabadi","year":"2020","journal-title":"JBMR Plus"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2024.10.011","article-title":"Revisiting vitamin D guidelines: A critical appraisal of the literature","volume":"30","author":"Holick","year":"2024","journal-title":"Endocr Pract"},{"key":"B32","doi-asserted-by":"publisher","first-page":"9895","DOI":"10.1038\/s41598-020-66889-8","article-title":"Preoperative vitamin D levels as a predictor of transient hypocalcemia and hypoparathyroidism after parathyroidectomy","volume":"10","author":"Unsal","year":"2020","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2020.105616","article-title":"Lower total 25-hydroxyvitamin D but no difference in calculated or measured free 25-hydroxyvitamin D serum levels in patients with primary hyperparathyroidism","volume":"199","author":"Meng","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S253246","article-title":"Evaluation of serum level of FGF23 and 1,25(OH)2D3 in primary hyperparathyroidism patients before and after parathyroidectomy","volume":"13","author":"Hassani","year":"2020","journal-title":"Int J Gen Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2020.105695","article-title":"Effect of vitamin D nutrition on disease indices in patients with primary hyperparathyroidism","volume":"201","author":"Rao","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.602221","article-title":"Clinical characteristics of primary hyperparathyroidism: 15-year experience of 457 patients in a single center in China","volume":"12","author":"Lin","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad103","article-title":"Morbidity associated with primary hyperparathyroidism-A population-based study with a subanalysis on vitamin D","volume":"108","author":"Soto-Pedre","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e64988","DOI":"10.7759\/cureus.64988","article-title":"Assessment of vitamin D status in primary hyperparathyroidism patients: A retrospective study","volume":"16","author":"Kolcsar","year":"2024","journal-title":"Cureus"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e60965","DOI":"10.7759\/cureus.60965","article-title":"Clinical, biochemical and surgical outcomes of primary hyperparathyroidism in the present era: A prospective study from a tertiary care hospital","volume":"16","author":"Misgar","year":"2024","journal-title":"Cureus"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-024-02422-2","article-title":"Vitamin D supplementation in primary hyperparathyroidism: effects on 1,25(OH)2 vitamin D and FGF23 levels","volume":"48","author":"Pallone","year":"2025","journal-title":"J Endocrinol Invest"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s13193-022-01676-7","article-title":"Differences in the Clinical Presentation and Biochemical Profile of the Patients with Primary Hyperparathyroidism with regard to their Serum Vitamin D Levels: a Single-center Experience","volume":"14","author":"Amal Dev","year":"2023","journal-title":"Indian J Surg Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02276-7","article-title":"The calcium-to-phosphorous (Ca\/P) ratio in the diagnosis of primary hyperparathyroidism and hypoparathyroidism: a multicentric study","volume":"68","author":"Madeo","year":"2020","journal-title":"Endocrine"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02485-0","article-title":"An analysis of calcium-to-phosphorus ratio in the diagnosis of normocalcemic primary hyperparathyroidism","volume":"71","author":"Ros\u00e1rio","year":"2021","journal-title":"Endocrine"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01473-5","article-title":"Safety and efficacy of common vitamin D supplementation in primary hyperparathyroidism and coexistent vitamin D deficiency and insufficiency: a systematic review and meta-analysis","volume":"44","author":"Song","year":"2021","journal-title":"J Endocrinol Invest"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1700345\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T05:16:51Z","timestamp":1764825411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1700345\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":44,"alternative-id":["10.3389\/fendo.2025.1700345"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1700345","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"article-number":"1700345"}}